Total Payments
$2,068
2024 Payments
$43.07
Companies
19
Transactions
98
Medicare Patients
3,361
Medicare Billing
$193,564
Payment Breakdown by Category
Food & Beverage$1,972 (95.4%)
Education$95.26 (4.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,972 | 96 | 95.4% |
| Education | $95.26 | 2 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $588.85 | 24 | $0 (2022) |
| GENZYME CORPORATION | $301.37 | 16 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $205.00 | 12 | $0 (2023) |
| Lilly USA, LLC | $176.39 | 9 | $0 (2023) |
| Janssen Biotech, Inc. | $127.94 | 7 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $103.29 | 4 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $79.99 | 1 | $0 (2021) |
| Organogenesis Inc. | $64.73 | 3 | $0 (2023) |
| Amgen Inc. | $64.53 | 3 | $0 (2022) |
| Biofrontera Inc. | $62.19 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $43.07 | 2 | ConvaTec Inc. ($24.71) |
| 2023 | $458.24 | 22 | GENZYME CORPORATION ($87.72) |
| 2022 | $812.23 | 39 | ABBVIE INC. ($313.44) |
| 2021 | $754.13 | 35 | AbbVie Inc. ($275.41) |
All Payment Transactions
98 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 03/13/2024 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: BioOncology | ||||||
| 08/15/2023 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $32.20 | General |
| Category: BioOncology | ||||||
| 06/27/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Immunology | ||||||
| 06/15/2023 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $22.40 | General |
| Category: DERMATOLOGY | ||||||
| 06/14/2023 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $19.54 | General |
| Category: DERMATOLOGY | ||||||
| 06/14/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Immunology | ||||||
| 06/01/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.49 | General |
| Category: Immunology | ||||||
| 05/31/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $30.14 | General |
| Category: Immunology | ||||||
| 05/25/2023 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $22.80 | General |
| Category: Wound Care | ||||||
| 05/18/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $24.80 | General |
| 05/10/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.82 | General |
| Category: Dermatology | ||||||
| 05/01/2023 | Genentech, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: BioOncology | ||||||
| 03/28/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Immunology | ||||||
| 03/23/2023 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 03/07/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Immunology | ||||||
| 03/02/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Immunology | ||||||
| 03/02/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.16 | General |
| Category: Immunology | ||||||
| 02/27/2023 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Immunology | ||||||
| 02/15/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.23 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/06/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Immunology | ||||||
| 02/02/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: ONCOLOGY | ||||||
| 01/24/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: ONCOLOGY | ||||||
| 01/19/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Immunology | ||||||
| 12/20/2022 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $18.89 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 827 | 1,145 | $166,529 | $39,820 |
| 2022 | 14 | 993 | 1,807 | $251,907 | $57,274 |
| 2021 | 13 | 802 | 1,647 | $226,893 | $52,625 |
| 2020 | 12 | 739 | 1,521 | $194,973 | $43,846 |
Total Patients
3,361
Total Services
6,120
Medicare Billing
$193,564
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 153 | 164 | $45,756 | $8,704 | 19.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 115 | 132 | $17,220 | $6,478 | 37.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 128 | 140 | $12,310 | $4,563 | 37.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 117 | 132 | $20,460 | $3,939 | 19.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 54 | 58 | $15,660 | $3,681 | 23.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 39 | $7,287 | $2,440 | 33.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 41 | 62 | $9,300 | $1,924 | 20.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 41 | 41 | $6,181 | $1,756 | 28.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 14 | 14 | $4,760 | $1,368 | 28.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $4,763 | $1,360 | 28.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $4,332 | $1,302 | 30.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 78 | 313 | $14,398 | $1,267 | 8.8% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 13 | 14 | $4,102 | $1,039 | 25.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 175 | 205 | $27,675 | $10,539 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 97 | 114 | $22,344 | $8,181 | 36.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 129 | 143 | $39,897 | $7,919 | 19.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 187 | 244 | $37,820 | $7,654 | 20.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 118 | 137 | $12,330 | $4,409 | 35.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 50 | 57 | $15,390 | $3,901 | 25.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 132 | 783 | $36,202 | $3,129 | 8.6% |
| 15788 | Chemical peel of outer layer of skin of face | Office | 2022 | 13 | 14 | $17,724 | $2,883 | 16.3% |
| 15792 | Chemical peel of outer layer of nonfacial skin | Office | 2022 | 11 | 14 | $16,380 | $2,438 | 14.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 17 | 21 | $7,140 | $1,938 | 27.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 13 | 17 | $8,279 | $1,683 | 20.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 27 | 32 | $4,800 | $1,046 | 21.8% |
About David Baker, PA
David Baker, PA is a Physician Assistant healthcare provider based in Fort Wayne, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/28/2009. The National Provider Identifier (NPI) number assigned to this provider is 1598998247.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Baker, PA has received a total of $2,068 in payments from pharmaceutical and medical device companies, with $43.07 received in 2024. These payments were reported across 98 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,972).
As a Medicare-enrolled provider, Baker has provided services to 3,361 Medicare beneficiaries, totaling 6,120 services with total Medicare billing of $193,564. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Fort Wayne, IN
- Active Since 08/28/2009
- Last Updated 11/15/2022
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1598998247
Products in Payments
- SKYRIZI (Biological) $470.78
- DUPIXENT (Biological) $425.09
- TALTZ (Drug) $176.39
- TREMFYA (Drug) $92.65
- COSENTYX (Biological) $73.61
- RINVOQ (Biological) $69.73
- Puraply (Medical Supply) $64.73
- Otezla (Drug) $64.53
- Erivedge (Biological) $63.39
- AMELUZ (Drug) $62.19
- LIBTAYO (Biological) $59.56
- OPZELURA (Drug) $51.41
- HUMIRA (Biological) $48.34
- EUCRISA (Drug) $43.42
- Sotyktu (Drug) $35.65
- REMICADE (Biological) $35.29
- INNOVAMATRIX AC (Device) $24.71
- Winlevi (Drug) $15.64
- IMBRUVICA (Drug) $15.58
- CIBINQO (Drug) $15.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Fort Wayne
A. Ferguson, Pa-C, PA-C
Physician Assistant — Payments: $17,525
Physician Assistant $17,525
Guinevere Nilles, Pa, PA
Physician Assistant — Payments: $11,751
Physician Assistant $11,751
Stephen Grote, Pa-C, PA-C
Physician Assistant — Payments: $11,375
Physician Assistant $11,375
Dana Lingel, Pa-C, PA-C
Physician Assistant — Payments: $9,784
Physician Assistant $9,784
Kristi Brennan, Pa-C, PA-C
Physician Assistant — Payments: $5,919
Physician Assistant $5,919
Jason Gaisford, Pa-C, PA-C
Physician Assistant — Payments: $5,129
Physician Assistant $5,129